Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment

Neurotoxicology and Teratology

Volumn 36, Issue , 2013, Pages 67-81

  Goines, Paula E ^a   Ashwood, Paul ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism spectrum disorder; Cytokine; Environment; Immunology; Neurodevelopment; Toxicant

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LEAD; MERCURY; ORGANOCHLORINE PESTICIDE; ORGANOPHOSPHATE PESTICIDE; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL DERIVATIVE; PYRETHROID; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTISM; CYTOKINE PRODUCTION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOPATHOLOGY; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CYTOKINES; ENVIRONMENT; HUMANS; NEURONS;

EID: 84875648076     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2012.07.006     Document Type: Article

References (354)

1. Aaltonen R., Heikkinen T., Hakala K., Laine K., Alanen A. Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol 2005, 106(4):802-807.
2. Abdallah M.W., Larsen N., Grove J., Norgaard-Pedersen B., Thorsen P., Mortensen E.L., et al. Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disorders. World J Biol Psychiatry 2011.
3. Adamson A.S., Collins K., Laurence A., O'Shea J.J. The Current STATus of lymphocyte signaling: new roles for old players. Curr Opin Immunol 2009, 21(2):161-166.
4. Albizzati A., More L., Di Candia D., Saccani M., Lenti C. Normal concentrations of heavy metals in autistic spectrum disorders. Minerva Pediatr 2012, 64(1):27-31.
5. Alleva E., Cirulli F., Bianchi M., Bondiolotti G.P., Chiarotti F., De Acetis L., et al. Behavioural characterization of interleukin-6 overexpressing or deficient mice during agonistic encounters. Eur J Neurosci 1998, 10(12):3664-3672.
6. Alm H., Kultima K., Scholz B., Nilsson A., Andren P.E., Fex-Svenningsen A., et al. Exposure to brominated flame retardant PBDE-99 affects cytoskeletal protein expression in the neonatal mouse cerebral cortex. Neurotoxicology 2008, 29(4):628-637.
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC.
8. Amir R.E., Van Den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23(2):185-188.
9. Anand S., Singh S., Nahar Saikia U., Bhalla A., Paul Sharma Y., Singh D. Cardiac abnormalities in acute organophosphate poisoning. Clin Toxicol (Phila) 2009, 47(3):230-235.
10. Andres D.A., Shi G.X., Bruun D., Barnhart C., Lein P.J. Rit signaling contributes to interferon-gamma-induced dendritic retraction via p38 mitogen-activated protein kinase activation. J Neurochem 2008, 107(5):1436-1447.
11. Araujo D.M., Cotman C.W. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res 1993, 600(1):49-55.
12. Armario A., Hernandez J., Bluethmann H., Hidalgo J. IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6. J Neuroimmunol 1998, 92(1-2):160-169.
13. Ashwood P., Anthony A., Torrente F., Wakefield A.J. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 2004, 24(6):664-673.
14. Ashwood P., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R.L., Croen L.A., et al. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 2008, 204(1-2):149-153.
15. Ashwood P., Schauer J., Pessah I.N., Van de Water J. Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders. J Neuroimmunol 2009, 208(1-2):130-135.
16. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2011, 25(1):40-45.
17. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Altered T cell responses in children with autism. Brain Behav Immun 2011, 25(5):840-849.
18. Atladottir H.O., Thorsen P., Ostergaard L., Schendel D.E., Lemcke S., Abdallah M., et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010, 40(12):1423-1430.
19. Bachiller D., Klingensmith J., Kemp C., Belo J.A., Anderson R.M., May S.R., et al. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature 2000, 403(6770):658-661.
20. Bagenstose L.M., Salgame P., Monestier M. Mercury-induced autoimmunity in the absence of IL-4. Clin Exp Immunol 1998, 114(1):9-12.
21. Bagenstose L.M., Salgame P., Monestier M. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol Res 1999, 20(1):67-78.
22. Balschun D., Wetzel W., Del Rey A., Pitossi F., Schneider H., Zuschratter W., et al. Interleukin-6: a cytokine to forget. FASEB J 2004, 18(14):1788-1790.
23. Banerjee B.D., Koner B.C., Ray A. Immunotoxicity of pesticides: perspectives and trends. Indian J Exp Biol 1996, 34(8):723-733.
24. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991, 259(3):988-996.
25. Banks W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 1994, 179(1-2):53-56.
26. Barcia C., Ros C.M., Annese V., Gomez A., Ros-Bernal F., Aguado-Yera D., et al. IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis 2011, 2:e142.
27. Barish M.E., Mansdorf N.B., Raissdana S.S. Gamma-interferon promotes differentiation of cultured cortical and hippocampal neurons. Dev Biol 1991, 144(2):412-423.
28. Barksby H.E., Lea S.R., Preshaw P.M., Taylor J.J. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 2007, 149(2):217-225.
29. Baron-Cohen S., Knickmeyer R.C., Belmonte M.K. Sex differences in the brain: implications for explaining autism. Science 2005, 310(5749):819-823.
30. Barrientos R.M., Frank M.G., Hein A.M., Higgins E.A., Watkins L.R., Rudy J.W., et al. Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection. Brain Behav Immun 2009, 23(1):46-54.
31. Bauer S., Kerr B.J., Patterson P.H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 2007, 8(3):221-232.
32. Beineke A., Siebert U., McLachlan M., Bruhn R., Thron K., Failing K., et al. Investigations of the potential influence of environmental contaminants on the thymus and spleen of harbor porpoises (Phocoena phocoena). Environ Sci Technol 2005, 39(11):3933-3938.
33. Beineke A., Siebert U., Muller G., Baumgartner W. Increased blood interleukin-10 mRNA levels in diseased free-ranging harbor porpoises (Phocoena phocoena). Vet Immunol Immunopathol 2007, 115(1-2):100-106.
34. Beineke A., Siebert U., Stott J., Muller G., Baumgartner W. Phenotypical characterization of changes in thymus and spleen associated with lymphoid depletion in free-ranging harbor porpoises (Phocoena phocoena). Vet Immunol Immunopathol 2007, 117(3-4):254-265.
35. Bellinger D., Dietrich K.N. Low-level lead exposure and cognitive function in children. Pediatr Ann 1994, 23(11):600-605.
36. Bellinger F.P., Madamba S.G., Campbell I.L., Siggins G.R. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett 1995, 198(2):95-98.
37. Bhatti G.K., Bhatti J.S., Kiran R., Sandhir R. Alterations in Ca(2) homeostasis and oxidative damage induced by ethion in erythrocytes of Wistar rats: ameliorative effect of vitamin E. Environ Toxicol Pharmacol 2011, 31(3):378-386.
38. Bilbo S.D. Early-life infection is a vulnerability factor for aging-related glial alterations and cognitive decline. Neurobiol Learn Mem 2010, 94(1):57-64.
39. Bilbo S.D., Schwarz J.M. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 2009, 3:14.
40. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J Neurosci 2005, 25(35):8000-8009.
41. Bilbo S.D., Levkoff L.H., Mahoney J.H., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection induces memory impairments following an immune challenge in adulthood. Behav Neurosci 2005, 119(1):293-301.
42. Bilbo S.D., Barrientos R.M., Eads A.S., Northcutt A., Watkins L.R., Rudy J.W., et al. Early-life infection leads to altered BDNF and IL-1beta mRNA expression in rat hippocampus following learning in adulthood. Brain Behav Immun 2008, 22(4):451-455.
43. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Annu Rev Immunol 1997, 15:749-795.
44. Boix J., Cauli O., Felipo V. Developmental exposure to polychlorinated biphenyls 52, 138 or 180 affects differentially learning or motor coordination in adult rats. Mechanisms involved. Neuroscience 2010, 167(4):994-1003.
45. Bondy G.S., Lefebvre D.E., Aziz S., Cherry W., Coady L., Maclellan E., et al. Toxicologic and immunologic effects of perinatal exposure to the brominated diphenyl ether (BDE) mixture DE-71 in the Sprague-Dawley rat. Environ Toxicol 2011, May 4 epub ahead of print. http://dx.doi.org/10.1002/tox.20713.
46. Bouchard M.F., Chevrier J., Harley K.G., Kogut K., Vedar M., Calderon N., et al. Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect 2011, 119(8):1189-1195.
47. Braida D., Sacerdote P., Panerai A.E., Bianchi M., Aloisi A.M., Iosue S., et al. Cognitive function in young and adult IL (interleukin)-6 deficient mice. Behav Brain Res 2004, 153(2):423-429.
48. Braunschweig D., Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., et al. Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 2008, 29(2):226-231.
49. Bridges C.C., Zalups R.K. Transport of inorganic mercury and methylmercury in target tissues and organs. J Toxicol Environ Health B Crit Rev 2010, 13(5):385-410.
50. Brionne T.C., Tesseur I., Masliah E., Wyss-Coray T. Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 2003, 40(6):1133-1145.
51. Buckwalter M.S., Wyss-Coray T. Modelling neuroinflammatory phenotypes in vivo. J Neuroinflammation 2004, 1(1):10.
52. Burchill M.A., Goetz C.A., Prlic M., O'Neil J.J., Harmon I.R., Bensinger S.J., et al. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J Immunol 2003, 171(11):5853-5864.
53. Butovsky O., Ziv Y., Schwartz A., Landa G., Talpalar A.E., Pluchino S., et al. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 2006, 31(1):149-160.
54. Byers D.E., Holtzman M.J. Alternatively activated macrophages and airway disease. Chest 2011, 140(3):768-774.
55. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 1993, 90(21):10061-10065.
56. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A 2006, 103(45):16834-16839.
57. Canesi L., Ciacci C., Betti M., Scarpato A., Citterio B., Pruzzo C., et al. Effects of PCB congeners on the immune function of Mytilus hemocytes: alterations of tyrosine kinase-mediated cell signaling. Aquat Toxicol 2003, 63(3):293-306.
58. Casida J.E. Pest toxicology: the primary mechanisms of pesticide action. Chem Res Toxicol 2009, 22(4):609-619.
59. CDC Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ 2012, 61(3):1-19.
60. Centers for Disease Control and Prevention Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009, 58(10):1-20.
61. Chakrabarty P., Ceballos-Diaz C., Beccard A., Janus C., Dickson D., Golde T.E., et al. IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. J Immunol 2010, 184(9):5333-5343.
62. Chapman S., Kadar T., Gilat E. Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain. Neurotoxicology 2006, 27(2):277-283.
63. Chen Y.J., Hsu C.C. Effects of prenatal exposure to PCBs on the neurological function of children: a neuropsychological and neurophysiological study. Dev Med Child Neurol 1994, 36(4):312-320.
64. Chess S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr 1977, 7(1):69-81.
65. Coburn C.G., Curras-Collazo M.C., Kodavanti P.R. In vitro effects of environmentally relevant polybrominated diphenyl ether (PBDE) congeners on calcium buffering mechanisms in rat brain. Neurochem Res 2008, 33(2):355-364.
66. Cohen D.J., Johnson W.T., Caparulo B.K. Pica and elevated blood lead level in autistic and atypical children. Am J Dis Child 1976, 130(1):47-48.
67. Corbin J.G., Kelly D., Rath E.M., Baerwald K.D., Suzuki K., Popko B. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 1996, 7(5):354-370.
68. Cordier S., Garel M., Mandereau L., Morcel H., Doineau P., Gosme-Seguret S., et al. Neurodevelopmental investigations among methylmercury-exposed children in French Guiana. Environ Res 2002, 89(1):1-11.
69. Costa L.G. Current issues in organophosphate toxicology. Clin Chim Acta 2006, 366(1-2):1-13.
70. Courchesne E., Mouton P.R., Calhoun M.E., Semendeferi K., Ahrens-Barbeau C., Hallet M.J., et al. Neuron number and size in prefrontal cortex of children with autism. JAMA 2011, 306(18):2001-2010.
71. Crinnion W.J. Chlorinated pesticides: threats to health and importance of detection. Altern Med Rev 2009, 14(4):347-359.
72. Croonenberghs J., Bosmans E., Deboutte D., Kenis G., Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 2002, 45(1):1-6.
73. da Silva A.G., Campello-Costa P., Linden R., Sholl-Franco A. Interleukin-4 blocks proliferation of retinal progenitor cells and increases rod photoreceptor differentiation through distinct signaling pathways. J Neuroimmunol 2008, 196(1-2):82-93.
74. Dahlgren J., Samuelsson A.M., Jansson T., Holmang A. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatr Res 2006, 60(2):147-151.
75. D'Amelio M., Ricci I., Sacco R., Liu X., D'Agruma L., Muscarella L.A., et al. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol Psychiatry 2005, 10(11):1006-1016.
76. Damodaran T.V., Greenfield S.T., Patel A.G., Dressman H.K., Lin S.K., Abou-Donia M.B. Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure. Neurochem Res 2006, 31(3):367-381.
77. Daniel V., Huber W., Bauer K., Suesal C., Conradt C., Opelz G. Associations of dichlorodiphenyltrichloroethane (DDT) 4.4 and dichlorodiphenyldichloroethylene (DDE) 4.4 blood levels with plasma IL-4. Arch Environ Health 2002, 57(6):541-547.
78. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav Immun 2001, 15(1):7-24.
79. Darnerud P.O., Eriksen G.S., Johannesson T., Larsen P.B., Viluksela M. Polybrominated diphenyl ethers: occurrence, dietary exposure, and toxicology. Environ Health Perspect 2001, 109(Suppl. 1):49-68.
80. Davis D., Safe S. Immunosuppressive activities of polychlorinated biphenyls in C57BL/6N mice: structure-activity relationships as Ah receptor agonists and partial antagonists. Toxicology 1990, 63(1):97-111.
81. de la Mano A., Gato A., Alonso M.I., Carnicero E., Martin C., Moro J.A. Role of interleukin-1beta in the control of neuroepithelial proliferation and differentiation of the spinal cord during development. Cytokine 2007, 37(2):128-137.
82. De Simone R., Levi G., Aloisi F. Interferon gamma gene expression in rat central nervous system glial cells. Cytokine 1998, 10(6):418-422.
83. De Vito P., Incerpi S., Pedersen J.Z., Luly P., Davis F.B., Davis P.J. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid 2011, 21(8):879-890.
84. DeFelice M.L., Ruchelli E.D., Markowitz J.E., Strogatz M., Reddy K.P., Kadivar K., et al. Intestinal cytokines in children with pervasive developmental disorders. Am J Gastroenterol 2003, 98(8):1777-1782.
85. Depino A.M., Lucchina L., Pitossi F. Early and adult hippocampal TGF-beta1 overexpression have opposite effects on behavior. Brain Behav Immun 2011, 25(8):1582-1591.
86. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 2010, 207(5):1067-1080.
87. Desoto M.C., Hitlan R.T. Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set. J Child Neurol 2007, 22(11):1308-1311.
88. DeStefano F. Vaccines and autism: evidence does not support a causal association. Clin Pharmacol Ther 2007, 82(6):756-759.
89. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64(1):61-78.
90. Dhote F., Peinnequin A., Carpentier P., Baille V., Delacour C., Foquin A., et al. Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 2007, 238(2-3):166-176.
91. Dieguez-Acuna F.J., Ellis M.E., Kushleika J., Woods J.S. Mercuric ion attenuates nuclear factor-kappaB activation and DNA binding in normal rat kidney epithelial cells: implications for mercury-induced nephrotoxicity. Toxicol Appl Pharmacol 2001, 173(3):176-187.
92. Diel F., Horr B., Borck H., Irman-Florjanc T. Pyrethroid insecticides influence the signal transduction in T helper lymphocytes from atopic and nonatopic subjects. Inflamm Res 2003, 52(4):154-163.
93. Dillman J.F., Phillips C.S., Kniffin D.M., Tompkins C.P., Hamilton T.A., Kan R.K. Gene expression profiling of rat hippocampus following exposure to the acetylcholinesterase inhibitor soman. Chem Res Toxicol 2009, 22(4):633-638.
94. Dingemans M.M., van Den Berg M., Westerink R.H. Neurotoxicity of brominated flame retardants: (in)direct effects of parent and hydroxylated polybrominated diphenyl ethers on the (developing) nervous system. Environ Health Perspect 2011, 119(7):900-907.
95. Doyle K.P., Cekanaviciute E., Mamer L.E., Buckwalter M.S. TGFbeta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflammation 2010, 7:62.
96. Dudley D.J., Hunter C., Varner M.W., Mitchell M.D. Elevation of amniotic fluid interleukin-4 concentrations in women with preterm labor and chorioamnionitis. Am J Perinatol 1996, 13(7):443-447.
97. Duramad P., Harley K., Lipsett M., Bradman A., Eskenazi B., Holland N.T., et al. Early environmental exposures and intracellular Th1/Th2 cytokine profiles in 24-month-old children living in an agricultural area. Environ Health Perspect 2006, 114(12):1916-1922.
98. Duramad P., Tager I.B., Leikauf J., Eskenazi B., Holland N.T. Expression of Th1/Th2 cytokines in human blood after in vitro treatment with chlorpyrifos, and its metabolites, in combination with endotoxin LPS and allergen Der p1. J Appl Toxicol 2006, 26(5):458-465.
99. Duysen E.G., Li B., Xie W., Schopfer L.M., Anderson R.S., Broomfield C.A., et al. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J Pharmacol Exp Ther 2001, 299(2):528-535.
100. Emanuele E., Orsi P., Boso M., Broglia D., Brondino N., Barale F., et al. Low-grade endotoxemia in patients with severe autism. Neurosci Lett 2010, 471(3):162-165.
101. Enstrom A.M., Van de Water J.A., Ashwood P. Autoimmunity in autism. Curr Opin Investig Drugs 2009, 10(5):463-473.
102. Enstrom A.M., Lit L., Onore C.E., Gregg J.P., Hansen R.L., Pessah I.N., et al. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun 2009, 23(1):124-133.
103. Enstrom A.M., Onore C.E., Van de Water J.A., Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 2010, 24(1):64-71.
104. Eriksson P., Fredriksson A. Neurotoxic effects in adult mice neonatally exposed to 3,3'4,4'5-pentachlorobiphenyl or 2,3,3'4,4'-pentachlorobiphenyl. Changes in brain nicotinic receptors and behaviour. Environ Toxicol Pharmacol 1998, 5(1):17-27.
105. Escary J.L., Perreau J., Dumenil D., Ezine S., Brulet P. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 1993, 363(6427):361-364.
106. Eskenazi B., Marks A.R., Bradman A., Harley K., Barr D.B., Johnson C., et al. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ Health Perspect 2007, 115(5):792-798.
107. Eskenazi B., Huen K., Marks A., Harley K.G., Bradman A., Barr D.B., et al. PON1 and neurodevelopment in children from the CHAMACOS study exposed to organophosphate pesticides in utero. Environ Health Perspect 2010, 118(12):1775-1781.
108. Fair P.A., Stavros H.C., Mollenhauer M.A., Dewitt J.C., Henry N., Kannan K., et al. Immune function in female B(6)C(3)F(1) mice is modulated by DE-71, a commercial polybrominated diphenyl ether mixture. J Immunotoxicol 2012, 9(1):96-107.
109. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002, 22(1):25-33.
110. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., Realmuto G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 2002, 52(8):805-810.
111. Fatemi S.H., Snow A.V., Stary J.M., Araghi-Niknam M., Reutiman T.J., Lee S., et al. Reelin signaling is impaired in autism. Biol Psychiatry 2005, 57(7):777-787.
112. Fatemi S.H., Reutiman T.J., Folsom T.D., Rooney R.J., Patel D.H., Thuras P.D. mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism. J Autism Dev Disord 2010, 40(6):743-750.
113. Filipek P.A., Accardo P.J., Baranek G.T., Cook E.H., Dawson G., Gordon B., et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999, 29(6):439-484.
114. Flohe S.B., Bruggemann J., Herder C., Goebel C., Kolb H. Enhanced proinflammatory response to endotoxin after priming of macrophages with lead ions. J Leukoc Biol 2002, 71(3):417-424.
115. Folkerth R.D., Keefe R.J., Haynes R.L., Trachtenberg F.L., Volpe J.J., Kinney H.C. Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol 2004, 14(3):265-274.
116. Fournier M., Degas V., Colborn T., Omara F.O., Denizeau F., Potworowski E.F., et al. Immunosuppression in mice fed on diets containing beluga whale blubber from the St Lawrence estuary and the Arctic populations. Toxicol Lett 2000, 112-113:311-317.
117. Fowles J.R., Fairbrother A., Baecher-Steppan L., Kerkvliet N.I. Immunologic and endocrine effects of the flame-retardant pentabromodiphenyl ether (DE-71) in C57BL/6J mice. Toxicology 1994, 86(1-2):49-61.
118. Gadient R.A., Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 1994, 637(1-2):10-14.
119. Gadient R.A., Otten U. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett 1994, 182(2):243-246.
120. Galloway T., Handy R. Immunotoxicity of organophosphorous pesticides. Ecotoxicology 2003, 12(1-4):345-363.
121. Garg S.K., Kipnis J., Banerjee R. IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes. J Neurochem 2009, 108(5):1155-1166.
122. Garry V.F., Harkins M.E., Erickson L.L., Long-Simpson L.K., Holland S.E., Burroughs B.L. Birth defects, season of conception, and sex of children born to pesticide applicators living in the Red River Valley of Minnesota, USA. Environ Health Perspect 2002, 110(Suppl. 3):441-449.
123. Gaspar-Ramirez O., Perez-Vazquez F.J., Pruneda-Alvarez L.G., Orta-Garcia S.T., Gonzalez-Amaro R., Perez-Maldonado I.N. Effect of polychlorinated biphenyls 118 and 153 on Th1/Th2 cells differentiation. Immunopharmacol Immunotoxicol 2012, 34(4):627-632.
124. Giulian D., Young D.G., Woodward J., Brown D.C., Lachman L.B. Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci 1988, 8(2):709-714.
125. Goebel C., Flohe S.B., Kirchhoff K., Herder C., Kolb H. Orally administered lead chloride induces bias of mucosal immunity. Cytokine 2000, 12(9):1414-1418.
126. Goines P., Haapanen L., Boyce R., Duncanson P., Braunschweig D., Delwiche L., et al. Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun 2011, 25(3):514-523.
127. Goines P.E., Croen L.A., Braunschweig D., Yoshida C.K., Grether J., Hansen R., et al. Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism 2011, 2:13.
128. Gomes F.C., Sousa Vde O., Romao L. Emerging roles for TGF-beta1 in nervous system development. Int J Dev Neurosci 2005, 23(5):413-424.
129. Goshen I., Kreisel T., Ounallah-Saad H., Renbaum P., Zalzstein Y., Ben-Hur T., et al. A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology 2007, 32(8-10):1106-1115.
130. Goth S.R., Chu R.A., Gregg J.P., Cherednichenko G., Pessah I.N. Uncoupling of ATP-mediated calcium signaling and dysregulated interleukin-6 secretion in dendritic cells by nanomolar thimerosal. Environ Health Perspect 2006, 114(7):1083-1091.
131. Griffin W.S., Sheng J.G., Roberts G.W., Mrak R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995, 54(2):276-281.
132. Grigorenko E.L., Han S.S., Yrigollen C.M., Leng L., Mizue Y., Anderson G.M., et al. Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 2008, 122(2):e438-e445.
133. Gu C., Goodarzi M., Yang X., Bian Y., Sun C., Jiang X. Predictive insight into the relationship between AhR binding property and toxicity of polybrominated diphenyl ethers by PLS-derived QSAR. Toxicol Lett 2012, 208(3):269-274.
134. Gupta S., Aggarwal S., Rashanravan B., Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 1998, 85(1):106-109.
135. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011, 68(11):1095-1102.
136. Hamaguchi M., Namera A., Tsuda N., Uejima T., Maruyama K., Kanai T., et al. Severe acute pancreatitis caused by organophosphate poisoning. Chudoku Kenkyu 2006, 19(4):395-399.
137. Handley M.T., Lian L.Y., Haynes L.P., Burgoyne R.D. Structural and functional deficits in a neuronal calcium sensor-1 mutant identified in a case of autistic spectrum disorder. PLoS One 2010, 5(5):e10534.
138. Hang C.H., Shi J.X., Tian J., Li J.S., Wu W., Yin H.X. Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats. Brain Res 2004, 1026(1):23-32.
139. Hayley S., Mangano E., Crowe G., Li N., Bowers W.J. An in vivo animal study assessing long-term changes in hypothalamic cytokines following perinatal exposure to a chemical mixture based on Arctic maternal body burden. Environ Health 2011, 10:65.
140. He P., He W., Wang A., Xia T., Xu B., Zhang M., et al. PBDE-47-induced oxidative stress, DNA damage and apoptosis in primary cultured rat hippocampal neurons. Neurotoxicology 2008, 29(1):124-129.
141. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003, 374(Pt 1):1-20.
142. Hemdan N.Y., Lehmann I., Wichmann G., Lehmann J., Emmrich F., Sack U. Immunomodulation by mercuric chloride in vitro: application of different cell activation pathways. Clin Exp Immunol 2007, 148(2):325-337.
143. Henderson R.F., Barr E.B., Blackwell W.B., Clark C.R., Conn C.A., Kalra R., et al. Response of rats to low levels of sarin. Toxicol Appl Pharmacol 2002, 184(2):67-76.
144. Henrich-Noack P., Prehn J.H., Krieglstein J. Neuroprotective effects of TGF-beta 1. J Neural Transm Suppl 1994, 43:33-45.
145. Herbstman J.B., Sjodin A., Kurzon M., Lederman S.A., Jones R.S., Rauh V., et al. Prenatal exposure to PBDEs and neurodevelopment. Environ Health Perspect 2010, 118(5):712-719.
146. Hertz-Picciotto I., Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology 2009, 20(1):84-90.
147. Hertz-Picciotto I., Green P.G., Delwiche L., Hansen R., Walker C., Pessah I.N. Blood mercury concentrations in CHARGE Study children with and without autism. Environ Health Perspect 2010, 118(1):161-166.
148. Heuer L., Braunschweig D., Ashwood P., Van de Water J., Campbell D.B. Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression. Transl Psychiatry 2011, 1.
149. Heupel K., Sargsyan V., Plomp J.J., Rickmann M., Varoqueaux F., Zhang W., et al. Loss of transforming growth factor-beta 2 leads to impairment of central synapse function. Neural Dev 2008, 3:25.
150. Heusinkveld H.J., Westerink R.H. Organochlorine insecticides lindane and dieldrin and their binary mixture disturb calcium homeostasis in dopaminergic PC12 cells. Environ Sci Technol 2012, 46(3):1842-1848.
151. Heyser C.J., Masliah E., Samimi A., Campbell I.L., Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A 1997, 94(4):1500-1505.
152. Hosoi E., Nishizaki C., Gallagher K.L., Wyre H.W., Matsuo Y., Sei Y. Expression of the ryanodine receptor isoforms in immune cells. J Immunol 2001, 167(9):4887-4894.
153. Howard A.S., Fitzpatrick R., Pessah I., Kostyniak P., Lein P.J. Polychlorinated biphenyls induce caspase-dependent cell death in cultured embryonic rat hippocampal but not cortical neurons via activation of the ryanodine receptor. Toxicol Appl Pharmacol 2003, 190(1):72-86.
154. Hsiao E.Y., Patterson P.H. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 2011, 25(4):604-615.
155. Hu J., Roy S.K., Shapiro P.S., Rodig S.R., Reddy S.P., Platanias L.C., et al. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem 2001, 276(1):287-297.
156. Huell M., Strauss S., Volk B., Berger M., Bauer J. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol 1995, 89(6):544-551.
157. Ihara S., Nakajima K., Fukada T., Hibi M., Nagata S., Hirano T., et al. Dual control of neurite outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6. EMBO J 1997, 16(17):5345-5352.
158. Ip P., Wong V., Ho M., Lee J., Wong W. Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol 2004, 19(6):431-434.
159. Ivarsson S.A., Bjerre I., Vegfors P., Ahlfors K. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 1990, 21(2):102-103.
160. Jenkins C., Roberts J., Wilson R., MacLean M.A., Shilito J., Walker J.J. Evidence of a T(H) 1 type response associated with recurrent miscarriage. Fertil Steril 2000, 73(6):1206-1208.
161. Jiang J., Tian K., Diao Y., Chen H., Zhu P., Wang Z. Expression of TNF alpha, IL-1 beta, IL-6 mRNA, release of TNF alpha in vital organs and their relationship with endotoxin translocation following hemorrhagic shock. Chin Med Sci J 1997, 12(1):41-46.
162. Johnson E.A., Kan R.K. The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. J Neuroinflammation 2010, 7:40.
163. Johnson-Restrepo B., Kannan K. An assessment of sources and pathways of human exposure to polybrominated diphenyl ethers in the United States. Chemosphere 2009 Jul, 76(4):542-548.
164. Jonakait G.M., Wei R., Sheng Z.L., Hart R.P., Ni L. Interferon-gamma promotes cholinergic differentiation of embryonic septal nuclei and adjacent basal forebrain. Neuron 1994, 12(5):1149-1159.
165. Jyonouchi H., Sun S., Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001, 120(1-2):170-179.
166. Kamel F., Hoppin J.A. Association of pesticide exposure with neurologic dysfunction and disease. Environ Health Perspect 2004, 112(9):950-958.
167. Kastin A.J., Akerstrom V., Pan W. Circulating TGF-beta1 does not cross the intact blood-brain barrier. J Mol Neurosci 2003, 21(1):43-48.
168. Katila H., Hanninen K., Hurme M. Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 1999, 4(2):179-181.
169. Kempuraj D., Asadi S., Zhang B., Manola A., Hogan J., Peterson E., et al. Mercury induces inflammatory mediator release from human mast cells. J Neuroinflammation 2010, 7:20.
170. Kenet T., Froemke R.C., Schreiner C.E., Pessah I.N., Merzenich M.M. Perinatal exposure to a noncoplanar polychlorinated biphenyl alters tonotopy, receptive fields, and plasticity in rat primary auditory cortex. Proc Natl Acad Sci U S A 2007, 104(18):7646-7651.
171. Kern J.K., Grannemann B.D., Trivedi M.H., Adams J.B. Sulfhydryl-reactive metals in autism. J Toxicol Environ Health A 2007, 70(8):715-721.
172. Kim K.H., Pessah I.N. Perinatal exposure to environmental polychlorinated biphenyls sensitizes hippocampus to excitotoxicity ex vivo. Neurotoxicology 2011, 32(6):981-985.
173. Kim I.J., Beck H.N., Lein P.J., Higgins D. Interferon gamma induces retrograde dendritic retraction and inhibits synapse formation. J Neurosci 2002, 22(11):4530-4539.
174. Kim S.H., Johnson V.J., Sharma R.P. Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-kappaB and p38 MAPK signaling pathways. Nitric Oxide 2002, 7(1):67-74.
175. Kim K.H., Inan S.Y., Berman R.F., Pessah I.N. Excitatory and inhibitory synaptic transmission is differentially influenced by two ortho-substituted polychlorinated biphenyls in the hippocampal slice preparation. Toxicol Appl Pharmacol 2009, 237(2):168-177.
176. Kim K.H., Bose D.D., Ghogha A., Riehl J., Zhang R., Barnhart C.D., et al. Para- and ortho-substitutions are key determinants of polybrominated diphenyl ether activity toward ryanodine receptors and neurotoxicity. Environ Health Perspect 2011, 119(4):519-526.
177. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994, 8(2):133-146.
178. Kiyota T., Okuyama S., Swan R.J., Jacobsen M.T., Gendelman H.E., Ikezu T. CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice. FASEB J 2010, 24(8):3093-3102.
179. Kodavanti P.R., Coburn C.G., Moser V.C., MacPhail R.C., Fenton S.E., Stoker T.E., et al. Developmental exposure to a commercial PBDE mixture, DE-71: neurobehavioral, hormonal, and reproductive effects. Toxicol Sci 2010, 116(1):297-312.
180. Kono D.H., Balomenos D., Pearson D.L., Park M.S., Hildebrandt B., Hultman P., et al. The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. J Immunol 1998, 161(1):234-240.
181. Kronborg C.S., Gjedsted J., Vittinghus E., Hansen T.K., Allen J., Knudsen U.B. Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet Gynecol Scand 2011, 90(7):791-796.
182. Krupinski J., Kumar P., Kumar S., Kaluza J. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 1996, 27(5):852-857.
183. Kumar V., Sercarz E. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J Immunol 1998, 161(12):6585-6591.
184. Kuperman D.A., Schleimer R.P. Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr Mol Med 2008, 8(5):384-392.
185. Kuratsune M., Yoshimura T., Matsuzaka J., Yamaguchi A. Yusho, a poisoning caused by rice oil contaminated with polychlorinated biphenyls. HSMHA Health Rep 1971, 86(12):1083-1091.
186. Kuriyama S.N., Wanner A., Fidalgo-Neto A.A., Talsness C.E., Koerner W., Chahoud I. Developmental exposure to low-dose PBDE-99: tissue distribution and thyroid hormone levels. Toxicology 2007, 242(1-3):80-90.
187. Kushima Y., Hama T., Hatanaka H. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci Res 1992, 13(4):267-280.
188. Labrousse V.F., Costes L., Aubert A., Darnaudery M., Ferreira G., Amedee T., et al. Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice. PLoS One 2009, 4(6):e6006.
189. Lahat N., Shapiro S., Froom P., Kristal-Boneh E., Inspector M., Miller A. Inorganic lead enhances cytokine-induced elevation of matrix metalloproteinase MMP-9 expression in glial cells. J Neuroimmunol 2002, 132(1-2):123-128.
190. Langeveld W.T., Meijer M., Westerink R.H. Differential effects of 20 non-dioxin-like PCBs on basal and depolarisation-evoked intracellular calcium levels in PC12 cells. Toxicol Sci 2012, 126(2):487-496.
191. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004, 74(3):552-557.
192. Lee L.C., Zachary A.A., Leffell M.S., Newschaffer C.J., Matteson K.J., Tyler J.D., et al. HLA-DR4 in families with autism. Pediatr Neurol 2006, 35(5):303-307.
193. Leijs M.M., Koppe J.G., Olie K., van Aalderen W.M., de Voogt P., ten Tusscher G.W. Effects of dioxins, PCBs, and PBDEs on immunology and hematology in adolescents. Environ Sci Technol 2009, 43(20):7946-7951.
194. Lein P.J., Yang D., Bachstetter A.D., Tilson H.A., Harry G.J., Mervis R.F., et al. Ontogenetic alterations in molecular and structural correlates of dendritic growth after developmental exposure to polychlorinated biphenyls. Environ Health Perspect 2007, 115(4):556-563.
195. Leipzig N.D., Xu C., Zahir T., Shoichet M.S. Functional immobilization of interferon-gamma induces neuronal differentiation of neural stem cells. J Biomed Mater Res A 2010, 93(2):625-633.
196. Lema S.C., Dickey J.T., Schultz I.R., Swanson P. Dietary exposure to 2,2',4,4'-tetrabromodiphenyl ether (PBDE-47) alters thyroid status and thyroid hormone-regulated gene transcription in the pituitary and brain. Environ Health Perspect 2008, 116(12):1694-1699.
197. Levin E.D., Addy N., Nakajima A., Christopher N.C., Seidler F.J., Slotkin T.A. Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Brain Res Dev Brain Res 2001, 130(1):83-89.
198. Levin E.D., Timofeeva O.A., Yang L., Petro A., Ryde I.T., Wrench N., et al. Early postnatal parathion exposure in rats causes sex-selective cognitive impairment and neurotransmitter defects which emerge in aging. Behav Brain Res 2010, 208(2):319-327.
199. Li Q. New mechanism of organophosphorus pesticide-induced immunotoxicity. J Nihon Med Sch 2007, 74(2):92-105.
200. Li A.J., Katafuchi T., Oda S., Hori T., Oomura Y. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res 1997, 748(1-2):30-38.
201. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009, 207(1-2):111-116.
202. Li L., Walker T.L., Zhang Y., Mackay E.W., Bartlett P.F. Endogenous interferon gamma directly regulates neural precursors in the non-inflammatory brain. J Neurosci 2010, 30(27):9038-9050.
203. Li Y., Innocentin S., Withers D.R., Roberts N.A., Gallagher A.R., Grigorieva E.F., et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011, 147(3):629-640.
204. Libbey J.E., Sweeten T.L., McMahon W.M., Fujinami R.S. Autistic disorder and viral infections. J Neurovirol 2005, 11(1):1-10.
205. Limke T.L., Otero-Montanez J.K., Atchison W.D. Evidence for interactions between intracellular calcium stores during methylmercury-induced intracellular calcium dysregulation in rat cerebellar granule neurons. J Pharmacol Exp Ther 2003, 304(3):949-958.
206. Loddick S.A., Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1996, 16(5):932-940.
207. Lord C., Rutter M., Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994, 24(5):659-685.
208. Lundgren M., Darnerud P.O., Blomberg J., Friman G., Ilback N.G. Polybrominated diphenyl ether exposure suppresses cytokines important in the defence to coxsackievirus B3 infection in mice. Toxicol Lett 2009, 184(2):107-113.
209. Malik M., Sheikh A.M., Wen G., Spivack W., Brown W.T., Li X. Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology 2011, 216(1-2):80-85.
210. Malkova N.V., Yu C.Z., Hsiao E.Y., Moore M.J., Patterson P.H. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 2012, 26(4):607-616.
211. Mangano E.N., Litteljohn D., So R., Nelson E., Peters S., Bethune C., et al. Interferon-gamma plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol Aging 2011, 33(7):1411-1426.
212. Mantel P.Y., Schmidt-Weber C.B. Transforming growth factor-beta: recent advances on its role in immune tolerance. Methods Mol Biol 2011, 677:303-338.
213. Markowitz P.I. Autism in a child with congenital cytomegalovirus infection. J Autism Dev Disord 1983, 13(3):249-253.
214. Martini F., Fernandez C., Segundo L.S., Tarazona J.V., Pablos M.V. Assessment of potential immunotoxic effects caused by cypermethrin, fluoxetine, and thiabendazole using heat shock protein 70 and interleukin-1beta mRNA expression in the anuran Xenopus laevis. Environ Toxicol Chem 2010, 29(11):2536-2543.
215. Martins T.B., Rose J.W., Jaskowski T.D., Wilson A.R., Husebye D., Seraj H.S., et al. Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay. Am J Clin Pathol 2011, 136(5):696-704.
216. Mason J.L., Suzuki K., Chaplin D.D., Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J Neurosci 2001, 21(18):7046-7052.
217. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 2009, 33(3):355-366.
218. Mense S.M., Sengupta A., Lan C., Zhou M., Bentsman G., Volsky D.J., et al. The common insecticides cyfluthrin and chlorpyrifos alter the expression of a subset of genes with diverse functions in primary human astrocytes. Toxicol Sci 2006, 93(1):125-135.
219. Messer A. Mini-review: polybrominated diphenyl ether (PBDE) flame retardants as potential autism risk factors. Physiol Behav 2010, 100(3):245-249.
220. Meyer U., Feldon J., Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr Res 2011, 69(5 Pt 2):26R-33R.
221. Miller L., Reynolds J. Autism and vaccination-the current evidence. J Spec Pediatr Nurs 2009, 14(3):166-172.
222. Mishra K.P. Lead exposure and its impact on immune system: a review. Toxicol In Vitro 2009, 23(6):969-972.
223. Mitchell K.A., Elferink C.J. Timing is everything: consequences of transient and sustained AhR activity. Biochem Pharmacol 2009, 77(6):947-956.
224. Mizuno T., Zhang G., Takeuchi H., Kawanokuchi J., Wang J., Sonobe Y., et al. Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor. FASEB J 2008, 22(6):1797-1806.
225. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006, 172(1-2):198-205.
226. Monteleone I., Rizzo A., Sarra M., Sica G., Sileri P., Biancone L., et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 2011, 141(1):237-248.
227. Moon L.D., Fawcett J.W. Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2. Eur J Neurosci 2001, 14(10):1667-1677.
228. Morgan J.T., Chana G., Pardo C.A., Achim C., Semendeferi K., Buckwalter J., et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 2010, 68(4):368-376.
229. Morse D.C., Groen D., Veerman M., van Amerongen C.J., Koeter H.B., Smits van Prooije A.E., et al. Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol Appl Pharmacol 1993, 122(1):27-33.
230. Murphy S.P., Tayade C., Ashkar A.A., Hatta K., Zhang J., Croy B.A. Interferon gamma in successful pregnancies. Biol Reprod 2009, 80(5):848-859.
231. Nagayama J., Tsuji H., Iida T., Nakagawa R., Matsueda T., Hirakawa H., et al. Immunologic effects of perinatal exposure to dioxins, PCBs and organochlorine pesticides in Japanese infants. Chemosphere 2007, 67(9):S393-S398.
232. Narayanan P.K., Carter W.O., Ganey P.E., Roth R.A., Voytik-Harbin S.L., Robinson J.P. Impairment of human neutrophil oxidative burst by polychlorinated biphenyls: inhibition of superoxide dismutase activity. J Leukoc Biol 1998, 63(2):216-224.
233. Ndebele K., Tchounwou P.B., McMurray R.W. Coumestrol, bisphenol-A, DDT, and TCDD modulation of interleukin-2 expression in activated CD+4 Jurkat T cells. Int J Environ Res Public Health 2004, 1(1):3-11.
234. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999, 17:701-738.
235. Nolan Y., Maher F.O., Martin D.S., Clarke R.M., Brady M.T., Bolton A.E., et al. Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J Biol Chem 2005, 280(10):9354-9362.
236. Nolting T., Lindecke A., Koutsilieri E., Maschke M., Husstedt I.W., Sopper S., et al. Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array. J Neurovirol 2009, 15(5-6):390-400.
237. Noren K., Meironyte D. Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20-30 years. Chemosphere 2000, 40(9-11):1111-1123.
238. Okada K., Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., et al. Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(1):187-190.
239. Oliphant C.J., Barlow J.L., McKenzie A.N. Insights into the initiation of type 2 immune responses. Immunology 2011, 134(4):378-385.
240. O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2000, 2000(44):re1.
241. Onore C., Careaga M., Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2011, 26(3):383-392.
242. Orlova K.A., Crino P.B. The tuberous sclerosis complex. Ann N Y Acad Sci 2010, 1184:87-105.
243. Owens S.E., Summar M.L., Ryckman K.K., Haines J.L., Reiss S., Summar S.R., et al. Lack of association between autism and four heavy metal regulatory genes. Neurotoxicology 2011, 32(6):769-775.
244. Pan W., Banks W.A., Kastin A.J. Permeability of the blood-brain and blood-spinal cord barriers to interferons. J Neuroimmunol 1997, 76(1-2):105-111.
245. Pancetti F., Olmos C., Dagnino-Subiabre A., Rozas C., Morales B. Noncholinesterase effects induced by organophosphate pesticides and their relationship to cognitive processes: implication for the action of acylpeptide hydrolase. J Toxicol Environ Health B Crit Rev 2007, 10(8):623-630.
246. Pasca S.P., Nemes B., Vlase L., Gagyi C.E., Dronca E., Miu A.C., et al. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 2006, 78(19):2244-2248.
247. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2009, 204(2):313-321.
248. Persico A.M., D'Agruma L., Maiorano N., Totaro A., Militerni R., Bravaccio C., et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 2001, 6(2):150-159.
249. Pessah I., Lein P.J. Chapter 19: Evidence for Environmental Susceptivility in Autism. What we know what we need to know about gene x environment interactions. Autism: Current Theories and Evidence 2008, Humana Press. A.W. Zimmerman (Ed.).
250. Pessah I.N., Lehmler H.J., Robertson L.W., Perez C.F., Cabrales E., Bose D.D., et al. Enantiomeric specificity of (-)-2,2',3,3',6,6'-hexachlorobiphenyl toward ryanodine receptor types 1 and 2. Chem Res Toxicol 2009, 22(1):201-207.
251. Pessah I.N., Cherednichenko G., Lein P.J. Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity. Pharmacol Ther 2010, 125(2):260-285.
252. Piton A., Michaud J.L., Peng H., Aradhya S., Gauthier J., Mottron L., et al. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet 2008, 17(24):3965-3974.
253. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005, 5(5):375-386.
254. Price C.S., Thompson W.W., Goodson B., Weintraub E.S., Croen L.A., Hinrichsen V.L., et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 2010, 126(4):656-664.
255. Rajakumar A., Chu T., Handley D.E., Bunce K.D., Burke B., Hubel C.A., et al. Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells. Placenta 2011, 32(1):70-78.
256. Reed A., Dzon L., Loganathan B.G., Whalen M.M. Immunomodulation of human natural killer cell cytotoxic function by organochlorine pesticides. Hum Exp Toxicol 2004, 23(10):463-471.
257. Reissmann E., Ernsberger U., Francis-West P.H., Rueger D., Brickell P.M., Rohrer H. Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons. Development 1996, 122(7):2079-2088.
258. Rivest S. Interactions between the immune and neuroendocrine systems. Prog Brain Res 2010, 181:43-53.
259. Roberts E.M., English P.B., Grether J.K., Windham G.C., Somberg L., Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect 2007, 115(10):1482-1489.
260. Roeyen G., Chapelle T., Jorens P., de Beeck B.O., Ysebaert D. Necrotizing pancreatitis due to poisoning with organophosphate pesticides. Acta Gastroenterol Belg 2008, 71(1):27-29.
261. Rogan W.J., Gladen B.C., Hung K.L., Koong S.L., Shih L.Y., Taylor J.S., et al. Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 1988, 241(4863):334-336.
262. Romero E., Guaza C., Castellano B., Borrell J. Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia. Mol Psychiatry 2010, 15(4):372-383.
263. Ronald A., Hoekstra R.A. Autism spectrum disorders and autistic traits: A decade of new twin studies. Am J Med Genet B Neuropsychiatr Genet 2011, 156B(3):255-274.
264. Rose S., Melnyk S., Savenka A., Hubanks A., Jernigan S., Cleves M., et al. The Frequency of Polymorphisms affecting Lead and Mercury Toxicity among Children with Autism. Am J Biochem Biotechnol 2008, 4(2):84-95.
265. Ross F.M., Allan S.M., Rothwell N.J., Verkhratsky A. A dual role for interleukin-1 in LTP in mouse hippocampal slices. J Neuroimmunol 2003, 144(1-2):61-67.
266. Rowley B., Monestier M. Mechanisms of heavy metal-induced autoimmunity. Mol Immunol 2005, 42(7):833-838.
267. Roze E., Meijer L., Bakker A., Van Braeckel K.N., Sauer P.J., Bos A.F. Prenatal exposure to organohalogens, including brominated flame retardants, influences motor, cognitive, and behavioral performance at school age. Environ Health Perspect 2009, 117(12):1953-1958.
268. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2003, 2(5):255-267.
269. Ruocco A., Nicole O., Docagne F., Ali C., Chazalviel L., Komesli S., et al. A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. J Cereb Blood Flow Metab 1999, 19(12):1345-1353.
270. Sakamoto M., Ikegami N., Nakano A. Protective effects of Ca2+ channel blockers against methyl mercury toxicity. Pharmacol Toxicol 1996, 78(3):193-199.
271. Samuelsson A.M., Jennische E., Hansson H.A., Holmang A. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am J Physiol Regul Integr Comp Physiol 2006, 290(5):R1345-R1356.
272. Savignac M., Mellstrom B., Naranjo J.R. Calcium-dependent transcription of cytokine genes in T lymphocytes. Pflugers Arch 2007, 454(4):523-533.
273. Schreiber T., Gassmann K., Gotz C., Hubenthal U., Moors M., Krause G., et al. Polybrominated diphenyl ethers induce developmental neurotoxicity in a human in vitro model: evidence for endocrine disruption. Environ Health Perspect 2010, 118(4):572-578.
274. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75(2):163-189.
275. Schug T.T., Janesick A., Blumberg B., Heindel J.J. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011, 127(3-5):204-215.
276. Schumann C.M., Amaral D.G. Stereological analysis of amygdala neuron number in autism. J Neurosci 2006, 26(29):7674-7679.
277. Selevan S.G., Rice D.C., Hogan K.A., Euling S.Y., Pfahles-Hutchens A., Bethel J. Blood lead concentration and delayed puberty in girls. N Engl J Med 2003, 348(16):1527-1536.
278. Serajee F.J., Nabi R., Zhong H., Huq M. Polymorphisms in xenobiotic metabolism genes and autism. J Child Neurol 2004, 19(6):413-417.
279. Seth V., Ahmad R.S., Suke S.G., Pasha S.T., Bhattacharya A., Banerjee B.D. Lindane-induced immunological alterations in human poisoning cases. Clin Biochem 2005, 38(7):678-680.
280. Shafer T.J., Meyer D.A., Crofton K.M. Developmental neurotoxicity of pyrethroid insecticides: critical review and future research needs. Environ Health Perspect 2005, 113(2):123-136.
281. Shannon M., Graef J.W. Lead intoxication in children with pervasive developmental disorders. J Toxicol Clin Toxicol 1996, 34(2):177-181.
282. Shatz C.J. MHC class I: an unexpected role in neuronal plasticity. Neuron 2009, 64(1):40-45.
283. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113(6):685-700.
284. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003, 23(1):297-302.
285. Shin K.J., Bae S.S., Hwang Y.A., Seo J.K., Ryu S.H., Suh P.G. 2,2',4,6,6'-pentachlorobiphenyl induces apoptosis in human monocytic cells. Toxicol Appl Pharmacol 2000, 169(1):1-7.
286. Sholl-Franco A., Marques P.M., Ferreira C.M., de Araujo E.G. IL-4 increases GABAergic phenotype in rat retinal cell cultures: involvement of muscarinic receptors and protein kinase C. J Neuroimmunol 2002, 133(1-2):20-29.
287. Sholl-Franco A., da Silva A.G., Adao-Novaes J. Interleukin-4 as a neuromodulatory cytokine: roles and signaling in the nervous system. Ann N Y Acad Sci 2009, 1153:65-75.
288. Singh V.K. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 1996, 66(1-2):143-145.
289. Skurlova M., Stofkova A., Jurcovicova J. Exogenous IL-1beta induces its own expression, but not that of IL-6 in the hypothalamus and activates HPA axis and prolactin release. Endocr Regul 2006, 40(4):125-128.
290. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007, 27(40):10695-10702.
291. Soderlund D.M. Molecular mechanisms of pyrethroid insecticide neurotoxicity: recent advances. Arch Toxicol 2012, 86(2):165-181.
292. Song J.H., Wang C.X., Song D.K., Wang P., Shuaib A., Hao C. Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway. J Biol Chem 2005, 280(13):12896-12901.
293. Spulber S., Oprica M., Bartfai T., Winblad B., Schultzberg M. Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL-1ra in the mouse. Eur J Neurosci 2008, 27(3):549-558.
294. Spulber S., Bartfai T., Winblad B., Schultzberg M. Morphological and behavioral changes induced by transgenic overexpression of interleukin-1ra in the brain. J Neurosci Res 2010, 89(2):142-152.
295. Spulber S., Bartfai T., Winblad B., Schultzberg M. Morphological and behavioral changes induced by transgenic overexpression of interleukin-1ra in the brain. J Neurosci Res 2011, 89(2):142-152.
296. Stamova B., Green P.G., Tian Y., Hertz-Picciotto I., Pessah I.N., Hansen R., et al. Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox Res 2011, 19(1):31-48.
297. State M.W., Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci 2011, 14(12):1499-1506.
298. Steuerwald U., Weihe P., Jorgensen P.J., Bjerve K., Brock J., Heinzow B., et al. Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. J Pediatr 2000, 136(5):599-605.
299. Stevens H.E., Smith K.M., Rash B.G., Vaccarino F.M. Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders. Front Neurosci 2010, 4.
300. Stoker T.E., Cooper R.L., Lambright C.S., Wilson V.S., Furr J., Gray L.E. In vivo and in vitro anti-androgenic effects of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture. Toxicol Appl Pharmacol 2005, 207(1):78-88.
301. Strijbos P.J., Rothwell N.J. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci 1995, 15(5 Pt 1):3468-3474.
302. Suzuki K., Matsuzaki H., Iwata K., Kameno Y., Shimmura C., Kawai S., et al. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 2011, 6(5):e20470.
303. Svensson I., Waara L., Johansson L., Bucht A., Cassel G. Soman-induced interleukin-1 beta mRNA and protein in rat brain. Neurotoxicology 2001, 22(3):355-362.
304. Sweeten T.L., Posey D.J., McDougle C.J. Brief report: autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord 2004, 34(5):583-586.
305. Sweeten T.L., Posey D.J., Shankar S., McDougle C.J. High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry 2004, 55(4):434-437.
306. Tabares-Seisdedos R., Rubenstein J.L. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Mol Psychiatry 2009, 14(6):563-589.
307. Tan Y., Li D., Song R., Lawrence D., Carpenter D.O. Ortho-substituted PCBs kill thymocytes. Toxicol Sci 2003, 76(2):328-337.
308. Thuvander A., Darnerud P.O. Effects of polybrominated diphenyl ether (PBDE) and polychlorinated biphenyl (PCB) on some immunological parameters after oral exposure in rats and mice. Toxicol Environ Chem 1999, 70:229-242.
309. Tian Y., Green P.G., Stamova B., Hertz-Picciotto I., Pessah I.N., Hansen R., et al. Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res 2011, 19(1):1-13.
310. Torre D., Broggini M., Zeroli C., Agrifoglio L., Botta V., Casalone R., et al. Serum levels of gamma interferon in patients with Down's syndrome. Infection 1995, 23(1):66-67.
311. Torres A.R., Maciulis A., Stubbs E.G., Cutler A., Odell D. The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum Immunol 2002, 63(4):311-316.
312. Torres A.R., Sweeten T.L., Cutler A., Bedke B.J., Fillmore M., Stubbs E.G., et al. The association and linkage of the HLA-A2 class I allele with autism. Hum Immunol 2006, 67(4-5):346-351.
313. Toscano C.D., Guilarte T.R. Lead neurotoxicity: from exposure to molecular effects. Brain Res Brain Res Rev 2005, 49(3):529-554.
314. Traugott U., Lebon P. Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J Neurol Sci 1988, 84(2-3):257-264.
315. Treves S., Vukcevic M., Jeannet P.Y., Levano S., Girard T., Urwyler A., et al. Enhanced excitation-coupled Ca(2+) entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with central core disease. Hum Mol Genet 2011, 20(3):589-600.
316. Tropepe V., Hitoshi S., Sirard C., Mak T.W., Rossant J., van der Kooy D. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 2001, 30(1):65-78.
317. Tsukimori K., Tokunaga S., Shibata S., Uchi H., Nakayama D., Ishimaru T., et al. Long-term effects of polychlorinated biphenyls and dioxins on pregnancy outcomes in women affected by the Yusho incident. Environ Health Perspect 2008, 116(5):626-630.
318. Valentino M., Rapisarda V., Santarelli L., Bracci M., Scorcelletti M., Di Lorenzo L., et al. Effect of lead on the levels of some immunoregulatory cytokines in occupationally exposed workers. Hum Exp Toxicol 2007, 26(7):551-556.
319. Van Birgelen A.P., Smit E.A., Kampen I.M., Groeneveld C.N., Fase K.M., Van der Kolk J., et al. Subchronic effects of 2,3,7,8-TCDD or PCBs on thyroid hormone metabolism: use in risk assessment. Eur J Pharmacol 1995, 293(1):77-85.
320. Varga E.A., Pastore M., Prior T., Herman G.E., McBride K.L. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 2009, 11(2):111-117.
321. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57(1):67-81.
322. Vashlishan A.B., Madison J.M., Dybbs M., Bai J., Sieburth D., Ch'ng Q., et al. An RNAi screen identifies genes that regulate GABA synapses. Neuron 2008, 58(3):346-361.
323. Vereyken E.J., Bajova H., Chow S., de Graan P.N., Gruol D.L. Chronic interleukin-6 alters the level of synaptic proteins in hippocampus in culture and in vivo. Eur J Neurosci 2007, 25(12):3605-3616.
324. Victorio S.C., Havton L.A., Oliveira A.L. Absence of IFNgamma expression induces neuronal degeneration in the spinal cord of adult mice. J Neuroinflammation 2010, 7:77.
325. Vig M., Kinet J.P. Calcium signaling in immune cells. Nat Immunol 2009, 10(1):21-27.
326. Vikman K.S., Owe-Larsson B., Brask J., Kristensson K.S., Hill R.H. Interferon-gamma-induced changes in synaptic activity and AMPA receptor clustering in hippocampal cultures. Brain Res 2001, 896(1-2):18-29.
327. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474(7351):380-384.
328. Vuillermot S., Weber L., Feldon J., Meyer U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 2010, 30(4):1270-1287.
329. Walter J., Honsek S.D., Illes S., Wellen J.M., Hartung H.P., Rose C.R., et al. A new role for interferon gamma in neural stem/precursor cell dysregulation. Mol Neurodegener 2011, 6:18.
330. Ward L.D., Howlett G.J., Discolo G., Yasukawa K., Hammacher A., Moritz R.L., et al. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol Chem 1994, 269(37):23286-23289.
331. Watanabe W., Shimizu T., Sawamura R., Hino A., Konno K., Kurokawa M. Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally. J Med Virol 2010, 82(6):1075-1082.
332. Waterman S.J., el-Fawal H.A., Snyder C.A. Lead alters the immunogenicity of two neural proteins: a potential mechanism for the progression of lead-induced neurotoxicity. Environ Health Perspect 1994, 102(12):1052-1056.
333. Wei H., Zou H., Sheikh A.M., Malik M., Dobkin C., Brown W.T., et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflammation 2011, 8:52.
334. Wens B., De Boever P., Maes M., Hollanders K., Schoeters G. Transcriptomics identifies differences between ultrapure non-dioxin-like polychlorinated biphenyls (PCBs) and dioxin-like PCB126 in cultured peripheral blood mononuclear cells. Toxicology 2011, 287(1-3):113-123.
335. Williams A.J., Berti R., Yao C., Price R.A., Velarde L.C., Koplovitz I., et al. Central neuro-inflammatory gene response following soman exposure in the rat. Neurosci Lett 2003, 349(3):147-150.
336. Winneke G. Developmental aspects of environmental neurotoxicology: lessons from lead and polychlorinated biphenyls. J Neurol Sci 2011, 308(1-2):9-15.
337. Wolansky M.J., Harrill J.A. Neurobehavioral toxicology of pyrethroid insecticides in adult animals: a critical review. Neurotoxicol Teratol 2008, 30(2):55-78.
338. Wong G., Goldshmit Y., Turnley A.M. Interferon-gamma but not TNF alpha promotes neuronal differentiation and neurite outgrowth of murine adult neural stem cells. Exp Neurol 2004, 187(1):171-177.
339. Woods R., Vallero R.O., Golub M., Suarez J.K., Ta T.A., Yasui D.H., et al. Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. Hum Mol Genet 2012, 21(11):2399-2411.
340. Wright B., Pearce H., Allgar V., Miles J., Whitton C., Leon I., et al. A Comparison of Urinary Mercury between Children with Autism Spectrum Disorders and Control Children. PLoS One 2012, 7(2):e29547.
341. Wu Z., Turner D.R., Oliveira D.B. IL-4 gene expression up-regulated by mercury in rat mast cells: a role of oxidant stress in IL-4 transcription. Int Immunol 2001, 13(3):297-304.
342. Wyss-Coray T., Feng L., Masliah E., Ruppe M.D., Lee H.S., Toggas S.M., et al. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am J Pathol 1995, 147(1):53-67.
343. Wyss-Coray T., Borrow P., Brooker M.J., Mucke L. Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice. J Neuroimmunol 1997, 77(1):45-50.
344. Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson T.J., O'Shea D.J., et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477(7363):171-178.
345. Yoshida T., Yasumura M., Uemura T., Lee S.J., Ra M., Taguchi R., et al. IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase delta. J Neurosci 2011, 31(38):13485-13499.
346. Yoshimatsu T., Kawaguchi D., Oishi K., Takeda K., Akira S., Masuyama N., et al. Non-cell-autonomous action of STAT3 in maintenance of neural precursor cells in the mouse neocortex. Development 2006, 133(13):2553-2563.
347. You Z., Luo C., Zhang W., Chen Y., He J., Zhao Q., et al. Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression. Behav Brain Res 2011, 225(1):135-141.
348. Yu L., Hebert M.C., Zhang Y.E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 2002, 21(14):3749-3759.
349. Zahir T., Chen Y.F., MacDonald J.F., Leipzig N., Tator C.H., Shoichet M.S. Neural stem/progenitor cells differentiate in vitro to neurons by the combined action of dibutyryl cAMP and interferon-gamma. Stem Cells Dev 2009, 18(10):1423-1432.
350. Zaretsky M.V., Alexander J.M., Byrd W., Bawdon R.E. Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 2004, 103(3):546-550.
351. Zhang J.D., Cousens L.S., Barr P.J., Sprang S.R. Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. Proc Natl Acad Sci U S A 1991, 88(8):3446-3450.
352. Zhang Y., Zhao M., Jin M., Xu C., Wang C., Liu W. Immunotoxicity of pyrethroid metabolites in an in vitro model. Environ Toxicol Chem 2010, 29(11):2505-2510.
353. Zhou J., Chen D.J., Liao Q.P., Yu Y.H. Impact of PBDE-209 exposure during pregnancy and lactation on immune function of offspring rats. Nan Fang Yi Ke Da Xue Xue Bao 2006, 26(6):738-741.
354. Ziats M.N., Rennert O.M. Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways. PLoS One 2011, 6(9):e24691.